BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 7023616)

  • 1. Characterization of a putative nicotinic acetylcholine receptor in mammalian brain.
    Morley BJ; Kemp GE
    Brain Res; 1981 Aug; 228(1):81-104. PubMed ID: 7023616
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on nicotinic acetylcholine receptors in mammalian brain VI. Isolation of a membrane fraction enriched in receptor function for different neurotransmitters.
    de Blas A; Mahler HR
    Biochem Biophys Res Commun; 1976 Sep; 72(1):24-32. PubMed ID: 985471
    [No Abstract]   [Full Text] [Related]  

  • 3. Myasthenia gravis: prototype of the antireceptor autoimmune diseases.
    Schönbeck S; Chrestel S; Hohlfeld R
    Int Rev Neurobiol; 1990; 32():175-200. PubMed ID: 1706686
    [No Abstract]   [Full Text] [Related]  

  • 4. Functional inhibition of acetylcholine receptors by antibodies in myasthenic sera.
    Hall ZW; Pizzighella S; Gu Y; Vicini S; Schuetze SM
    Ann N Y Acad Sci; 1987; 505():272-85. PubMed ID: 2446552
    [No Abstract]   [Full Text] [Related]  

  • 5. Nicotinic receptors in sensory ganglia.
    Polz-Tejera G; Hunt SP; Schmidt J
    Brain Res; 1980 Aug; 195(1):223-30. PubMed ID: 6967343
    [No Abstract]   [Full Text] [Related]  

  • 6. Detection of nicotinic cholinergic transmission in Malapterurus electricus electroplax.
    Eldefrawi ME; Shaker N; Mansour NA; Warnick JE; Albuquerque EX
    Life Sci; 1981 Sep; 29(10):1033-7. PubMed ID: 7289769
    [No Abstract]   [Full Text] [Related]  

  • 7. Regional and subcellular distribution of cholinergic enzyme and receptor activity in goldfish brain.
    Francis A; Schechter N
    Neuroscience; 1980; 5(2):293-301. PubMed ID: 7374943
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibody to acetylcholine receptor increases degradation of junctional and extrajunctional receptors in adult muscle.
    Reiness CG; Weinberg CB; Hall ZW
    Nature; 1978 Jul; 274(5666):68-70. PubMed ID: 661996
    [No Abstract]   [Full Text] [Related]  

  • 9. Acetylcholine receptors and end-plate electrophysiology in myasthenia gravis.
    Ito Y; Miledi R; Vincent A; Newsom-Davis J
    Brain; 1978 Jun; 101(2):345-68. PubMed ID: 667602
    [No Abstract]   [Full Text] [Related]  

  • 10. Accelerated degradation of acetylcholine receptor from cultured rat myotubes with myasthenia gravis sera and globulins.
    Appel SH; Anwyl R; McAdams MW; Elias S
    Proc Natl Acad Sci U S A; 1977 May; 74(5):2130-4. PubMed ID: 266734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of iodine 125 alpha-bungarotoxin to the thymus of mice.
    Ohshima F; Kondo K; Tsubaki T
    Arch Neurol; 1978 Jan; 35(1):31-2. PubMed ID: 619869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies against muscle and brain nicotinic acetylcholine receptors in IgA-deficient patients with epilepsy.
    Fontana A; Fulpius BW; Cuénoud S
    Adv Cytopharmacol; 1979; 3():287-92. PubMed ID: 474298
    [No Abstract]   [Full Text] [Related]  

  • 13. Alpha-bungarotoxin binding and central nervous system nicotinic acetylcholine receptors.
    Oswald RE; Freeman JA
    Neuroscience; 1981; 6(1):1-14. PubMed ID: 7012663
    [No Abstract]   [Full Text] [Related]  

  • 14. Degradation rate of nicotinic acetylcholine receptor from goldfish brain.
    Oswald RE; Freeman JA
    Brain Res; 1980 Apr; 187(2):499-503. PubMed ID: 7370746
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of a putative nicotinic acetylcholine receptor in fractions from housefly brain [proceedings].
    Harris R; Cattell KJ; Donnellan JF
    Biochem Soc Trans; 1979 Feb; 7(1):136-8. PubMed ID: 437257
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-acetylcholine receptor antibodies in myasthenia gravis: binding to membrane-bound Torpedo AChR.
    Koethe SM; DuPont BL; Calvo AM; Otterson G; McQuillen MP
    Ann N Y Acad Sci; 1987; 505():557-65. PubMed ID: 3479936
    [No Abstract]   [Full Text] [Related]  

  • 17. A non-immunogenic myasthenia gravis model and its application in a study of transsynaptic regulation at the neuromuscular junction.
    Molenaar PC; Oen BS; Plomp JJ; Van Kempen GT; Jennekens FG; Hesselmans LF
    Eur J Pharmacol; 1991 Apr; 196(1):93-101. PubMed ID: 1874282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct binding studies of 125 I-alpha-bungarotoxin and 3H-quinuclidinyl benzilate interaction with axon plasma membrane fragments. Evidence for nicotinic and muscarinic binding sites.
    Marquis JK; Hilt DC; Mautner HG
    Biochem Biophys Res Commun; 1977 Sep; 78(2):476-82. PubMed ID: 907696
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of acetylcholine receptor antibodies in myasthenia gravis.
    Appel SH; Elias SB; Chauvin P
    Fed Proc; 1979 Sep; 38(10):2381-5. PubMed ID: 478014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotinic cholinergic receptors labeled by [3H]acetylcholine in rat brain.
    Schwartz RD; McGee R; Kellar KJ
    Mol Pharmacol; 1982 Jul; 22(1):56-62. PubMed ID: 7121451
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.